Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2002-2-14
pubmed:abstractText
In palliative first-line treatment of colorectal cancer, the secondary resection of distant metastases after downstaging has constantly gained in importance. The objective of this prospective study was to examine the tumor response rate, the toxicity, the median survival time and the prognostic impact of metastatic resection after downstaging of consecutively enrolled patients with primary nonresectable colorectal cancer treated with once weekly 24-hour (24-h) infusion of high-dose 5-fluorouracil (5-FU) and folinic acid.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0923-7534
pubmed:author
pubmed:issnType
Print
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1721-7
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:11843250-Aged, pubmed-meshheading:11843250-Antimetabolites, Antineoplastic, pubmed-meshheading:11843250-Colorectal Neoplasms, pubmed-meshheading:11843250-Combined Modality Therapy, pubmed-meshheading:11843250-Female, pubmed-meshheading:11843250-Fluorouracil, pubmed-meshheading:11843250-Humans, pubmed-meshheading:11843250-Infusions, Intravenous, pubmed-meshheading:11843250-Kidney Neoplasms, pubmed-meshheading:11843250-Leucovorin, pubmed-meshheading:11843250-Liver Neoplasms, pubmed-meshheading:11843250-Lung Neoplasms, pubmed-meshheading:11843250-Male, pubmed-meshheading:11843250-Middle Aged, pubmed-meshheading:11843250-Neoplasm Staging, pubmed-meshheading:11843250-Palliative Care, pubmed-meshheading:11843250-Prognosis, pubmed-meshheading:11843250-Prospective Studies, pubmed-meshheading:11843250-Survival Rate
pubmed:year
2001
pubmed:articleTitle
Impact of surgery on survival in palliative patients with metastatic colorectal cancer after first line treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and folinic acid.
pubmed:affiliation
Department of Internal Medicine I, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany. Axel.Wein@med1.imed.uni-erlangen.de
pubmed:publicationType
Journal Article, Clinical Trial, Clinical Trial, Phase II